美国 · SEC FORM 4
Perspective Therapeutics, Inc.
CATX · NYSE · CIK 0000728387 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
7 同一窗口内观察到的 Form 4 交易行
7 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-13 · Hunt Jonathan Robert.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 16,570,625
- 上期报告
- 22,806,291
- 日均成交量
- 3,002,054
- 回补天数
- 5.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-13 | Hunt Jonathan Robert | 买入 (P) | Common Stock | 11,000 | USD 2.03 | USD 22,330 | SEC 申报 ↗ |
| 2025-11-12 | Williamson Robert F III | 买入 (P) | Common Stock | 9,498 | USD 2.10 | USD 19,946 | SEC 申报 ↗ |
| 2025-03-31 | Woods Lori A | 买入 (P) | Common Stock | 23,475 | USD 2.13 | USD 50,002 | SEC 申报 ↗ |
| 2025-03-31 | Williamson Robert F III | 买入 (P) | Common Stock | 38,145 | USD 2.14 | USD 81,630 | SEC 申报 ↗ |
| 2025-03-28 | Williamson Robert F III | 买入 (P) | Common Stock | 22,192 | USD 2.27 | USD 50,376 | SEC 申报 ↗ |
| 2025-03-28 | Spoor Johan M. | 买入 (P) | Common Stock | 26,676 | USD 2.23 | USD 59,615 | SEC 申报 ↗ |
| 2025-03-28 | Graham Juan | 买入 (P) | Common Stock | 33,333 | USD 2.25 | USD 74,999 | SEC 申报 ↗ |
| 2024-12-04 | HENSON HEIDI | 买入 (P) | Common Stock | 25,975 | USD 3.85 | USD 100,004 | SEC 申报 ↗ |
| 2024-12-04 | Spoor Johan M. | 买入 (P) | Common Stock | 8,000 | USD 3.77 | USD 30,160 | SEC 申报 ↗ |
| 2024-11-25 | Williamson Robert F III | 买入 (P) | Common Stock | 6,266 | USD 3.64 | USD 22,814 | SEC 申报 ↗ |
| 2024-11-25 | Hunt Jonathan Robert | 买入 (P) | Common Stock | 12,829 | USD 3.82 | USD 48,974 | SEC 申报 ↗ |
| 2024-11-25 | Spoor Johan M. | 买入 (P) | Common Stock | 26,500 | USD 3.79 | USD 100,410 | SEC 申报 ↗ |
| 2024-06-17 | Hunt Jonathan Robert | 买入 (P) | Common Stock | 1,800 | USD 9.82 | USD 17,676 | SEC 申报 ↗ |
| 2024-06-14 | Woods Lori A | 买入 (P) | Common Stock | 4,587 | USD 10.90 | USD 49,990 | SEC 申报 ↗ |
| 2024-06-13 | Spoor Johan M. | 买入 (P) | Common Stock | 100,000 | USD 1.17 | USD 117,000 | SEC 申报 ↗ |
Form 4 申报证据
9 transaction lines in the latest 365-day window; 94 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 167,149 | USD 3.15 | USD 526,519 | SEC 申报 ↗ |
| 2026-09-03 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 80,783 | USD 3.11 | USD 251,235 | SEC 申报 ↗ |
| 2026-09-02 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 42,129 | USD 3.11 | USD 131,021 | SEC 申报 ↗ |
展开近期 Form 4 证据 (9 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 167,149 | USD 3.15 | USD 526,519 | SEC 申报 ↗ |
| 2026-09-03 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 80,783 | USD 3.11 | USD 251,235 | SEC 申报 ↗ |
| 2026-09-02 | Lantheus Alpha Therapy, LLC; Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 42,129 | USD 3.11 | USD 131,021 | SEC 申报 ↗ |
| 2026-09-01 | Lantheus Alpha Therapy, LLC | 卖出 (S) | Common Stock | 35,769 | USD 3.12 | USD 111,599 | SEC 申报 ↗ |
| 2026-09-01 | Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 35,769 | USD 3.12 | USD 111,599 | SEC 申报 ↗ |
| 2026-08-31 | Lantheus Alpha Therapy, LLC | 卖出 (S) | Common Stock | 78,145 | USD 3.14 | USD 245,375 | SEC 申报 ↗ |
| 2026-08-31 | Lantheus Holdings, Inc. | 卖出 (S) | Common Stock | 78,145 | USD 3.14 | USD 245,375 | SEC 申报 ↗ |
| 2025-11-13 | Hunt Jonathan Robert | 买入 (P) | Common Stock | 11,000 | USD 2.03 | USD 22,330 | SEC 申报 ↗ |
| 2025-11-12 | Williamson Robert F III | 买入 (P) | Common Stock | 9,498 | USD 2.10 | USD 19,946 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CATX |
| CIK | 0000728387 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 94 transaction lines from 2020-02-03 to 2026-09-04 71 P purchase lines · 7 S sale lines · 16 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.